行情

PACB

PACB

太平洋生物科学
NASDAQ

实时行情|Nasdaq Last Sale

5.63
-0.02
-0.35%
盘后: 5.63 0 0.00% 16:46 09/20 EDT
开盘
5.63
昨收
5.65
最高
5.67
最低
5.54
成交量
134.92万
成交额
--
52周最高
7.84
52周最低
3.900
市值
8.61亿
市盈率(TTM)
-7.4787
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

PACB 新闻

  • 外盘头条:特朗普再次呼吁美联储将利率降至零以下
  • 新浪美股.2小时前
  • 华为苹果正面交锋 同时发布新品谁主沉浮?
  • 证券日报.4小时前
  • 德国银行业协会预计该国GDP增长率为0.5%
  • 新浪美股.6小时前
  • 特朗普呼吁将利率降至零以下:我们应比别人少付利息
  • 新浪美股.7小时前

更多

所属板块

先进医疗设备和技术
-0.70%
医疗设备和用品
-0.22%

热门股票

名称
价格
涨跌幅

PACB 简况

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.
展开

Webull提供Pacific Biosciences of California的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。